GKL-Biotec AG
Pharmaceuticals - Dielsdorf, Zürich, Switzerland
GKL-Biotec AG Employees
GKL-Biotec AG Details
GKL BIOTEC AG - a subsidiary of the company group Klett-LochBased on continuous and intensive research on active pharmaceutical ingredients (API's) in the field of Thymic Peptides, the company GKL-BIOTEC-AG was founded in January 2008. We focus on the development of active ingredients for the pharmaceutical and cosmetics industry. In close cooperation with renowned universities we promote the technological transfer of biochemical innovations. The existing results have underlined the success of our approach.Thymic peptides are known as key molecules for the effectivity of the human immune system. Regulatory effects of thymic peptides on T-cell functions were already discovered in the 1980s by Goldstein, Stevenson, Fauci etc., currently continued and reconfirmed by Professor Richard Boyd.Professor C. Birr (Heidelberg) developed within the scope of a seven year research project a bovine-free mimicry of the natural total thymus extract = bovine-free statistic thymic tetra peptide libraryThe bovine-free peptide library GKL-02/03 is highly effective, save, patented, worldwide unique and bears decisive advantages vs. the natural thymic total extract. Not to be confused with a polymer.
GKL-Biotec AG Technologies
Email Providers
Outlook
Customer Reviews
TrustedShops
Load Balancers
Apache
Tag Management
Google Tag Manager
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework